Clerio Vision
PrivateLast Round
Series E
Extension
Mar 20, 2023
Est. Valuation
$180M
Total Funding Raised
$39.02M
Company Overview
Clerio Vision operates in Healthcare & Life Sciences and is based in Rochester, New York. Its latest recorded funding round was a Series E Extension round in March 2023.
Clerio Vision is a medical device company developing a non-invasive vision correction platform using femtosecond laser technology for application in contact lenses, corneas, and intraocular lenses.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clerio Vision Comparables
Compare Clerio Vision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perfect Lens | 73% | |
| Alcon | 73% | |
| Ziemer Ophthalmic Systems AG | 73% |
For institutional investors. Book with your work email.
Clerio Vision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E Extension | Mar 20, 2023 | ||||
| Series E | Mar 18, 2021 | ||||
| Series D | Jul 10, 2019 | ||||
| Grant | Sep 15, 2017 | ||||
| Series A | Jul 1, 2017 | ||||
Grant | Jan 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Clerio Vision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bridge Point Capital | Series E Extension, Series E |
| Topmark Partners | Series D, Series A, Seed |
| Norwest Venture Partners | Series E |
| Safar Partners | Series D, Series E Extension, Series E |
| Cranberry Capital | Series A |
| Armory Square Ventures | Series D, Series A, Seed |
| Hegemon Capital | Series E Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 79% MoM.
- May 3, 2025
Monthly visitors grew 202% MoM, from 397 to 1.2K.
For institutional investors. Book with your work email.
Clerio Vision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clerio Vision's valuation, stock price, and market status.
Is Clerio Vision a public or private company?
Clerio Vision is a private company.
What is the current stock price of Clerio Vision?
Clerio Vision is a private company, so its shares have no public market price. Caplight tracks Clerio Vision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clerio Vision worth (valuation)?
Clerio Vision's valuation is estimated at $180.0M based on funding round data.
Can I buy Clerio Vision stock?
Clerio Vision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clerio Vision's last funding round?
Clerio Vision's most recent funding round was Series E Extension on March 20, 2023.
Who are the main investors in Clerio Vision?
Key investors in Clerio Vision include Bridge Point Capital, Safar Partners.
Will Clerio Vision IPO soon?
No public IPO plans have been announced for Clerio Vision.
How can I track Clerio Vision secondary market activity?
Caplight tracks bids, offers, and trades in Clerio Vision's shares on secondary markets.